ArticleHemaSphere2025

Outcomes of tafasitamab and lenalidomide in large B-cell lymphoma based on prior CD19-directed CAR T exposure.

Mwanasha H Merrill et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.